Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × copanlisib × Clear all

NCT06218667 2024-10-31

A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer

Phase 1/2 Withdrawn

Prostatic Neoplasms